## What the headline *really* says: strong top-line, but “quality of earnings” questions linger EPAM’s release shows a clean growth story on the surface—Q4 2025 revenue of **$1.408B (+12.8% Y/Y)** and FY2025 revenue of **$5.457B (+15.4% Y/Y)**—which is normally the kind of print that should stabilize sentiment. ["Fourth Quarter 2025 Revenues of $1.408 billion, up 12.8% year-over-year"](https://www.prnewswire.com/news-releases/epam-reports-results-for-fourth-quarter-and-full-year-2025-302692245.html) ["Full Year 2025 Revenues of $5.457 billion, up 15.4% year-over-year"](https://www.prnewswire.com/news-releases/epam-reports-results-for-fourth-quarter-and-full-year-2025-302692245.html) But “alpha between the lines” starts with the gap between GAAP and non-GAAP profitability and EPS. In Q4, EPAM reported **GAAP operating margin of 10.6% vs non-GAAP operating margin of 16.3%**, and **GAAP diluted EPS of $1.98 vs non-GAAP diluted EPS of $3.26**—a spread that invites investors to interrogate what’s being adjusted out and whether that delta is cyclical or structural. ["GAAP Income from Operations was 10.6%"](https://www.prnewswire.com/news-releases/epam-reports-results-for-fourth-quarter-and-full-year-2025-302692245.html) ["Non-GAAP Income from Operations was 16.3%"](https://www.prnewswire.com/news-releases/epam-reports-results-for-fourth-quarter-and-full-year-2025-302692245.html) ["GAAP Diluted EPS of $1.98"](https://www.prnewswire.com/news-releases/epam-reports-results-for-fourth-quarter-and-full-year-2025-302692245.html) ["Non-GAAP Diluted EPS of $3.26"](https://www.prnewswire.com/news-releases/epam-reports-results-for-fourth-quarter-and-full-year-2025-302692245.html) ## The market’s “tell”: FY growth, yet GAAP EPS *down* The most important tension in the release is that **FY2025 revenue grew 15.4% Y/Y**, while **FY2025 GAAP diluted EPS decreased 14.3% Y/Y**. That combination often reads as: growth is present, but not fully translating into GAAP per-share earnings power—exactly the kind of nuance that can drive an outsized negative reaction when the market is positioned for operating leverage. ["Full Year 2025 Revenues of $5.457 billion, up 15.4% year-over-year"](https://www.prnewswire.com/news-releases/epam-reports-results-for-fourth-quarter-and-full-year-2025-302692245.html) ["GAAP Diluted EPS of $6.72, a decrease of 14.3%"](https://www.prnewswire.com/news-releases/epam-reports-results-for-fourth-quarter-and-full-year-2025-302692245.html) Even more subtly, the company highlights FY2025 **non-GAAP diluted EPS up 5.9% Y/Y**—which reinforces that the “debate” is not whether EPAM can grow, but what investors should pay for that growth given the GAAP/non-GAAP bridge and the durability of margins. ["Non-GAAP Diluted EPS of $11.50, an increase of 5.9%"](https://www.prnewswire.com/news-releases/epam-reports-results-for-fourth-quarter-and-full-year-2025-302692245.html) ## Management is already pivoting the narrative to 2026+ (and that’s not accidental) Separately—and importantly for interpreting today’s communication strategy—EPAM has already filed an 8‑K disclosing an **Investor Day on March 12, 2026**, explicitly framed as a forum to share its **long-term growth strategy** around the “next wave of AI-driven business transformation.” That sequencing can be read as management anticipating a need to “reset” or sharpen the long-term narrative for investors beyond any near-term guideposts. ["will hold an Investor Day on March 12, 2026"](0001352010-26-000005|0) ["Sharing Long-Term Growth Strategy for the Next Wave of AI-Driven Business Transformation"](0001352010-26-000005|1) Management also states the Investor Day will “outline how we are positioning EPAM for sustained growth through 2026 and beyond,” which is effectively a signal that the company wants the market focused on multi-year positioning—not just the next quarter’s slope. ["positioning EPAM for sustained growth through 2026 and beyond"](0001352010-26-000005|1) ## The actionable takeaway (where the “hidden alpha” sits) The release, on its face, is not “bad numbers”—it’s **good growth with a credibility test on earnings quality and conversion to GAAP EPS**, plus an intentional push toward a longer-duration AI transformation story ahead of a dedicated Investor Day. ["Full Year 2025 Revenues of $5.457 billion, up 15.4% year-over-year"](https://www.prnewswire.com/news-releases/epam-reports-results-for-fourth-quarter-and-full-year-2025-302692245.html) ["GAAP Diluted EPS of $6.72, a decrease of 14.3%"](https://www.prnewswire.com/news-releases/epam-reports-results-for-fourth-quarter-and-full-year-2025-302692245.html) ["Investor Day on March 12, 2026"](0001352010-26-000005|1) If you want, paste EPAM’s **2026 full-year and Q1 outlook lines** from the release (or tell me the key ranges), and I’ll translate *exactly* what in the guidance likely triggered the magnitude of the premarket move—still grounded strictly in the disclosed language and numbers.

## What the headline *really* says: strong top-line, but “quality of earnings” questions linger EPAM’s release shows a clean growth story on the surface—Q4 2025 revenue of **$1.408B (+12.8% Y/Y)** and FY2025 revenue of **$5.457B (+15.4% Y/Y)**—which is normally the kind of print that should stabilize sentiment. ["Fourth Quarter 2025 Revenues of $1.408 billion, up 12.8% year-over-year"](https://www.prnewswire.com/news-releases/epam-reports-results-for-fourth-quarter-and-full-year-2025-302692245.html) ["Full Year 2025 Revenues of $5.457 billion, up 15.4% year-over-year"](https://www.prnewswire.com/news-releases/epam-reports-results-for-fourth-quarter-and-full-year-2025-302692245.html) But “alpha between the lines” starts with the gap between GAAP and non-GAAP profitability and EPS. In Q4, EPAM reported **GAAP operating margin of 10.6% vs non-GAAP operating margin of 16.3%**, and **GAAP diluted EPS of $1.98 vs non-GAAP diluted EPS of $3.26**—a spread that invites investors to interrogate what’s being adjusted out and whether that delta is cyclical or structural. ["GAAP Income from Operations was 10.6%"](https://www.prnewswire.com/news-releases/epam-reports-results-for-fourth-quarter-and-full-year-2025-302692245.html) ["Non-GAAP Income from Operations was 16.3%"](https://www.prnewswire.com/news-releases/epam-reports-results-for-fourth-quarter-and-full-year-2025-302692245.html) ["GAAP Diluted EPS of $1.98"](https://www.prnewswire.com/news-releases/epam-reports-results-for-fourth-quarter-and-full-year-2025-302692245.html) ["Non-GAAP Diluted EPS of $3.26"](https://www.prnewswire.com/news-releases/epam-reports-results-for-fourth-quarter-and-full-year-2025-302692245.html) ## The market’s “tell”: FY growth, yet GAAP EPS *down* The most important tension in the release is that **FY2025 revenue grew 15.4% Y/Y**, while **FY2025 GAAP diluted EPS decreased 14.3% Y/Y**. That combination often reads as: growth is present, but not fully translating into GAAP per-share earnings power—exactly the kind of nuance that can drive an outsized negative reaction when the market is positioned for operating leverage. ["Full Year 2025 Revenues of $5.457 billion, up 15.4% year-over-year"](https://www.prnewswire.com/news-releases/epam-reports-results-for-fourth-quarter-and-full-year-2025-302692245.html) ["GAAP Diluted EPS of $6.72, a decrease of 14.3%"](https://www.prnewswire.com/news-releases/epam-reports-results-for-fourth-quarter-and-full-year-2025-302692245.html) Even more subtly, the company highlights FY2025 **non-GAAP diluted EPS up 5.9% Y/Y**—which reinforces that the “debate” is not whether EPAM can grow, but what investors should pay for that growth given the GAAP/non-GAAP bridge and the durability of margins. ["Non-GAAP Diluted EPS of $11.50, an increase of 5.9%"](https://www.prnewswire.com/news-releases/epam-reports-results-for-fourth-quarter-and-full-year-2025-302692245.html) ## Management is already pivoting the narrative to 2026+ (and that’s not accidental) Separately—and importantly for interpreting today’s communication strategy—EPAM has already filed an 8‑K disclosing an **Investor Day on March 12, 2026**, explicitly framed as a forum to share its **long-term growth strategy** around the “next wave of AI-driven business transformation.” That sequencing can be read as management anticipating a need to “reset” or sharpen the long-term narrative for investors beyond any near-term guideposts. ["will hold an Investor Day on March 12, 2026"](0001352010-26-000005|0) ["Sharing Long-Term Growth Strategy for the Next Wave of AI-Driven Business Transformation"](0001352010-26-000005|1) Management also states the Investor Day will “outline how we are positioning EPAM for sustained growth through 2026 and beyond,” which is effectively a signal that the company wants the market focused on multi-year positioning—not just the next quarter’s slope. ["positioning EPAM for sustained growth through 2026 and beyond"](0001352010-26-000005|1) ## The actionable takeaway (where the “hidden alpha” sits) The release, on its face, is not “bad numbers”—it’s **good growth with a credibility test on earnings quality and conversion to GAAP EPS**, plus an intentional push toward a longer-duration AI transformation story ahead of a dedicated Investor Day. ["Full Year 2025 Revenues of $5.457 billion, up 15.4% year-over-year"](https://www.prnewswire.com/news-releases/epam-reports-results-for-fourth-quarter-and-full-year-2025-302692245.html) ["GAAP Diluted EPS of $6.72, a decrease of 14.3%"](https://www.prnewswire.com/news-releases/epam-reports-results-for-fourth-quarter-and-full-year-2025-302692245.html) ["Investor Day on March 12, 2026"](0001352010-26-000005|1) If you want, paste EPAM’s **2026 full-year and Q1 outlook lines** from the release (or tell me the key ranges), and I’ll translate *exactly* what in the guidance likely triggered the magnitude of the premarket move—still grounded strictly in the disclosed language and numbers.